Lewy body dementia (LBD) is a prevalent yet often overlooked neurodegenerative disorder. Characterized by abnormal protein deposits in the brain, called Lewy bodies, LBD causes cognitive decline, visual hallucinations, movement difficulties, and fluctuating alertness. Early recognition and diagnosis are crucial for appropriate management and support.
This document discusses Lewy body dementia, including its clinical features such as visual hallucinations and parkinsonism. It describes two types of Lewy body dementia: diffuse Lewy body disease, which presents at an early age with widespread Lewy body formation and rapid progression, and Lewy body variant of Alzheimer's disease, which presents later in life with mild parkinsonism and global cognitive impairment. The diagnosis, medications used to treat it such as cholinesterase inhibitors and antiparkinson drugs, and behavioral management strategies are also outlined.
As a psychiatrist at Mount Auburn Hospital in Cambridge, Massachusetts, Dr. Antonio Bullon treats patients with dementia and other neuropsychiatric illnesses. Focused on geriatric care since 2012, Dr. Antonio Bullon draws on an in-depth knowledge of Lewy body dementia.
Lewy Body Dementia vs. Alzheimer's: A Quick ComparisonHeather Johnson
Lewy body dementia and Alzheimer's disease can be hard to differentiate from one another. We understand how difficult it is to manage LBD and Alzheimer's. Since there is no complete therapy at this time, they are even more concerning. Visit us for more information.
This document provides an overview of dementia, including its definition, diagnosis, causes, and approach to evaluation and management. It defines dementia as acquired cognitive impairment that interferes with daily life. The diagnostic criteria from the DSM-V are outlined. Common causes of dementia like Alzheimer's disease, vascular dementia, and Lewy body dementia are reviewed. The document discusses taking a history, performing a physical and neurological exam, cognitive testing, and medical investigations to diagnose the underlying cause of dementia.
common ask question:
Is memory loss a natural part of ageing?
Why can’t I remember as well as my wife?
Is it normal to write notes to myself?
Why can’t I remember names?
Is it normal to forget why I went into the kitchen?
Sometimes my mind just goes blank, normal?
Can I slow age related memory changes?
Dementia is an umbrella term used to cover several conditions that all result in the decline of a patient's cognitive abilities. Learn about the different types of Dementia.
Dementia is a syndrome involving the deterioration of memory, thinking, behavior and the ability to perform everyday activities. It is caused by damage to brain cells that interferes with communication between cells. Alzheimer's disease is the most common form of dementia, potentially contributing to 60-70% of cases. Dementia is diagnosed based on medical history, exams, tests and characteristic changes in thinking and functioning. While there is no cure, medications and therapies can help reduce symptoms or slow progression for some time.
Dementia is a progressive deterioration of cognitive functions such as memory, thinking, and reasoning caused by underlying brain changes. It was first described in the 1st century AD and termed "dementia" in the 18th century. Alzheimer's disease, the most common type, accounts for 50-75% of cases. Dementia is diagnosed based on cognitive assessments and is staged based on severity of symptoms from normal forgetfulness to severe impairment requiring full time care. Management involves treating underlying causes, minimizing risks, and providing support to patients and their caregivers.
This document discusses Lewy body dementia, including its clinical features such as visual hallucinations and parkinsonism. It describes two types of Lewy body dementia: diffuse Lewy body disease, which presents at an early age with widespread Lewy body formation and rapid progression, and Lewy body variant of Alzheimer's disease, which presents later in life with mild parkinsonism and global cognitive impairment. The diagnosis, medications used to treat it such as cholinesterase inhibitors and antiparkinson drugs, and behavioral management strategies are also outlined.
As a psychiatrist at Mount Auburn Hospital in Cambridge, Massachusetts, Dr. Antonio Bullon treats patients with dementia and other neuropsychiatric illnesses. Focused on geriatric care since 2012, Dr. Antonio Bullon draws on an in-depth knowledge of Lewy body dementia.
Lewy Body Dementia vs. Alzheimer's: A Quick ComparisonHeather Johnson
Lewy body dementia and Alzheimer's disease can be hard to differentiate from one another. We understand how difficult it is to manage LBD and Alzheimer's. Since there is no complete therapy at this time, they are even more concerning. Visit us for more information.
This document provides an overview of dementia, including its definition, diagnosis, causes, and approach to evaluation and management. It defines dementia as acquired cognitive impairment that interferes with daily life. The diagnostic criteria from the DSM-V are outlined. Common causes of dementia like Alzheimer's disease, vascular dementia, and Lewy body dementia are reviewed. The document discusses taking a history, performing a physical and neurological exam, cognitive testing, and medical investigations to diagnose the underlying cause of dementia.
common ask question:
Is memory loss a natural part of ageing?
Why can’t I remember as well as my wife?
Is it normal to write notes to myself?
Why can’t I remember names?
Is it normal to forget why I went into the kitchen?
Sometimes my mind just goes blank, normal?
Can I slow age related memory changes?
Dementia is an umbrella term used to cover several conditions that all result in the decline of a patient's cognitive abilities. Learn about the different types of Dementia.
Dementia is a syndrome involving the deterioration of memory, thinking, behavior and the ability to perform everyday activities. It is caused by damage to brain cells that interferes with communication between cells. Alzheimer's disease is the most common form of dementia, potentially contributing to 60-70% of cases. Dementia is diagnosed based on medical history, exams, tests and characteristic changes in thinking and functioning. While there is no cure, medications and therapies can help reduce symptoms or slow progression for some time.
Dementia is a progressive deterioration of cognitive functions such as memory, thinking, and reasoning caused by underlying brain changes. It was first described in the 1st century AD and termed "dementia" in the 18th century. Alzheimer's disease, the most common type, accounts for 50-75% of cases. Dementia is diagnosed based on cognitive assessments and is staged based on severity of symptoms from normal forgetfulness to severe impairment requiring full time care. Management involves treating underlying causes, minimizing risks, and providing support to patients and their caregivers.
Lewy body dementia was first discovered in the early 1900s and involves protein deposits in the brain that affect brain function and cause Parkinson's-like symptoms. It can be difficult to diagnose due to similarities with Parkinson's disease, but indicators include progressive cognitive decline, fluctuating cognition and attention, visual hallucinations, and REM sleep behavior disorder. Treatments include medications to slow cognitive decline and manage Parkinsonism symptoms, as well as non-pharmacological therapies and counseling. An accurate diagnosis allows for better symptom management and quality of life.
Dementias are acquired cognitive impairments that affect memory, language, visuospatial ability, and other mental functions, impairing daily living. The most common type is Alzheimer's disease, which results from neuronal disruption and loss. A thorough evaluation involves assessing onset and progression of symptoms, neuropsychiatric features, physical exam including brief cognitive tests, and ruling out other treatable causes. The leading cause is Alzheimer's disease, whose risk increases dramatically with age and involves memory loss and other cognitive deficits that gradually worsen over years.
RUNNING HEAD Medical Disorders2Periodic Limb Moveme.docxtodd581
RUNNING HEAD: Medical Disorders 2
Periodic Limb Movement Disorder & Restless Leg Syndrome
Chelsea Reese
The University of Alabama at Birmingham
PSY 488: Kristin T. Avis, Ph.D., CBSM
December 14, 2018
Abstract
The restless legs syndrome (RLS) and periodic limb movement disorder (PLMD) can be separated but overlapping sicknesses. Both feature night-living happening by chance, without any planning occasional limb movements that can cause sleep disruption, but each has separate medicine-based features that are clearly connected with or related to the management of the patient. The cause of RLS is made by meeting established medicine-based judging needed things, not from discovery of occasional limb movements of sleep (PLMS) on a sleep study. PLMD does require the presence of PLMS on polysomnography as well as a connected sleep complaint. Both PLMS and RLS can happen with other sleep problems as well as in healthy people. Treatment of RLS is based on the pattern and extremeness of the problem, with rgic drugs generally liked for/preferred for first treatment. Anticonvulsants, pain-relieving drugs, and drugs that cause sleep also have a role. A treatment set of computer instructions is given to help with the management of RLS. Treatment of PLMD depends on many of the same medicines but is generally more plain/honest/easy and places a greater reliance on levodopa compounds and drug that calms or causes sleep.
Periodic Limb Movement Disorder (PLMD)
This disorder is characterized by repeated and uncontrollable movements of arms or legs occurring during sleep. This condition may affect the legs and arms and is sometimes confused with restless leg syndrome. This condition causes brief muscle twitches and leg kicks. The involuntary movements of limbs causes sleep disturbances or insomnia and a child suffering from this condition usually experiences other mental, physical, behavioral or social problems seen during the day.
As a result of disturbed sleep at night, the child may experience daytime sleepiness. However, the exact cause of this problem is not known but is associated with a family history of this condition. Low iron levels, nerve problems, poor blood circulation and kidney disorders are also common causes of this problem. This condition is also associated with other sleep problems such as narcolepsy and restless leg syndrome
To diagnose this problem, a parent may notice the signs at night when the child is sleeping, an overnight sleep study is often required to confirm the diagnosis along with other medical and physical examination such ad blood tests to determine the iron levels.
Treatment
Children and adolescents with PLMD are advised to have good sleep hygiene by having enough sleep and having regular sleep patterns, the children should also avoid caffeine as it worsens the symptoms of PLMD. In case the iron level are.
RUNNING HEAD Medical Disorders2Periodic Limb Moveme.docxglendar3
RUNNING HEAD: Medical Disorders 2
Periodic Limb Movement Disorder & Restless Leg Syndrome
Chelsea Reese
The University of Alabama at Birmingham
PSY 488: Kristin T. Avis, Ph.D., CBSM
December 14, 2018
Abstract
The restless legs syndrome (RLS) and periodic limb movement disorder (PLMD) can be separated but overlapping sicknesses. Both feature night-living happening by chance, without any planning occasional limb movements that can cause sleep disruption, but each has separate medicine-based features that are clearly connected with or related to the management of the patient. The cause of RLS is made by meeting established medicine-based judging needed things, not from discovery of occasional limb movements of sleep (PLMS) on a sleep study. PLMD does require the presence of PLMS on polysomnography as well as a connected sleep complaint. Both PLMS and RLS can happen with other sleep problems as well as in healthy people. Treatment of RLS is based on the pattern and extremeness of the problem, with rgic drugs generally liked for/preferred for first treatment. Anticonvulsants, pain-relieving drugs, and drugs that cause sleep also have a role. A treatment set of computer instructions is given to help with the management of RLS. Treatment of PLMD depends on many of the same medicines but is generally more plain/honest/easy and places a greater reliance on levodopa compounds and drug that calms or causes sleep.
Periodic Limb Movement Disorder (PLMD)
This disorder is characterized by repeated and uncontrollable movements of arms or legs occurring during sleep. This condition may affect the legs and arms and is sometimes confused with restless leg syndrome. This condition causes brief muscle twitches and leg kicks. The involuntary movements of limbs causes sleep disturbances or insomnia and a child suffering from this condition usually experiences other mental, physical, behavioral or social problems seen during the day.
As a result of disturbed sleep at night, the child may experience daytime sleepiness. However, the exact cause of this problem is not known but is associated with a family history of this condition. Low iron levels, nerve problems, poor blood circulation and kidney disorders are also common causes of this problem. This condition is also associated with other sleep problems such as narcolepsy and restless leg syndrome
To diagnose this problem, a parent may notice the signs at night when the child is sleeping, an overnight sleep study is often required to confirm the diagnosis along with other medical and physical examination such ad blood tests to determine the iron levels.
Treatment
Children and adolescents with PLMD are advised to have good sleep hygiene by having enough sleep and having regular sleep patterns, the children should also avoid caffeine as it worsens the symptoms of PLMD. In case the iron level are.
Neurocognitive disorders (NCDs) include conditions involving significant cognitive decline from previous levels of functioning. Major subtypes include those due to Alzheimer's disease, vascular factors, Lewy bodies, Parkinson's disease, frontotemporal deficits, traumatic brain injury, HIV, Huntington's disease, prion disease, or multiple etiologies. Delirium is characterized by acute changes in attention and cognition. Diagnosis of major or mild NCD due to conditions like Alzheimer's disease requires evidence of cognitive impairment in multiple domains interfering with daily life. Vascular NCD results from cerebrovascular disease and impairment occurs in step-like progression following small strokes in the brain.
The document discusses psychiatric manifestations that commonly occur in dementia such as Alzheimer's disease and dementia with Lewy bodies. It describes symptoms such as apathy, anxiety, agitation, and depression. Psychotic symptoms like hallucinations and delusions are also addressed. The prevalence of various neuropsychiatric symptoms is provided for mild cognitive impairment and different stages of Alzheimer's disease and dementia with Lewy bodies. Factors that influence the risk of developing certain psychiatric symptoms are also outlined.
This document discusses major and mild neurocognitive disorders. It defines neurocognitive disorders as involving cognitive decline and impairment, with mild disorders having slight decline in one function and major disorders having severe decline in one or more functions. It lists several types of neurocognitive disorders including Alzheimer's disease, vascular disorders, frontotemporal disorders, and disorders due to traumatic brain injury, Lewy bodies, Parkinson's disease, prion diseases, and substance abuse. Symptoms vary but include memory loss, confusion, impaired language and motor skills. Treatment involves testing, medication, and psychosocial support.
Presentation made by Drs. Charles Driscoll and Ms. Angela Taylor at the live webinar hosted by AlzPossible on the 29th of May, 2014. See recording at http://www.alzpossible.org/wordpress-3.1.4/wordpress/webinars-2/dementia-with-lewy-bodies/
The document summarizes key aspects of neurocognitive disorders as outlined in Chapter 7. It describes three main groups - delirium, major or minor neurocognitive disorders (dementia), and amnestic disorders. Delirium is a temporary state of confusion that can have various causes and usually resolves quickly if the underlying cause is treated. Dementia involves a gradual loss of cognitive abilities that impairs daily life; it has various causes like Alzheimer's disease or vascular issues. Assessment and management aim to address any underlying causes or provide support, as the condition is often not reversible.
The document provides information about East Central Regional Hospital and mental retardation/developmental disabilities. It discusses the hospital's mission, vision, and values in providing care. It then covers various topics related to mental retardation including definitions, classifications, causes, characteristics, diagnosis criteria. It notes the hospital serves those with mental illnesses, substance abuse, and mental retardation through a variety of treatment modalities.
This document provides information about dementia, including:
1. Dementia is characterized by progressive deterioration of intellect, behavior, and personality due to diffuse brain disease, especially affecting the cortex and hippocampus. Memory impairment is required for diagnosis.
2. Symptoms include memory loss, abnormal behavior, intellectual decline, mood changes, and difficulty with daily tasks. Insight is initially retained but lost over time.
3. Causes of dementia include Alzheimer's disease (60% of cases), cerebrovascular disease, neurodegenerative diseases, infections, head injuries, and tumors. Dementia must be distinguished from delirium and depression.
This document discusses different types and classifications of disabilities. It defines disability and outlines three dimensions recognized by the ICF: body structure/function, activities, and participation. It then describes common types of disabilities including physical, intellectual, sensory, and mental illnesses. Specific conditions are explained for each type. The document also discusses differences between impairments, disabilities, and handicaps.
P.S.Jagadeesh Kumar, "Bi-directional Recurrent Neural Networks in Classifying Dementia, Alzheimer’s Disease and Autism Spectrum Disorder", The Art of Fixing Alzheimer’s Disease, April, 2019, Dorrance Publishing Co., Pittsburgh, Pennsylvania, United States.
This document provides information on geriatric psychiatry and aging-related mental health issues. It discusses several key topics:
1. Age-related changes in physiological functioning can increase vulnerability over time. Late adulthood begins around age 65 and is characterized by gradual decline in functioning of body systems.
2. Life expectancy has been increasing in India and globally, leading to growth in the elderly population. Common concerns for elderly include retirement, economic insecurity, declining health, and loss of independence.
3. Major mental health disorders in elderly include depression, delirium, and dementia. Late-life depression can present differently than depression in younger populations. Delirium is an acute change in mental status that commonly affects hospital
Today Schizophrenia awareness week starts. (From 22 May 2022 to 28th May 2022). Theme for this year is "Connecting with Hope". I have tried my best to cover everything about schizophrenia a type of severe mental illness.
This document discusses delirium and dementia. It defines delirium as a disturbance of consciousness and cognition that develops rapidly. Common causes include medical conditions, substances, and trauma. Dementia involves a progressive decline in cognitive functions due to brain damage or disease. Alzheimer's disease is the most common cause of dementia. The document stages the progression of Alzheimer's disease from no symptoms to severe cognitive decline. It also discusses various types of dementia and their neurological underpinnings.
Dementia is an acquired global impairment of intellect, memory and personality but without impairment of consciousness“
Or
According to WHO
Dementia is a syndrome in which there is deterioration in cognitive function beyond what might be expected from the usual consequences of biological ageing.
Dementia is an umbrella term that can affect even young individuals. This presentation investigates causes, assessment, diagnosis, and treatment options.
Jennifer Schaus and Associates hosts a complimentary webinar series on The FAR in 2024. Join the webinars on Wednesdays and Fridays at noon, eastern.
Recordings are on YouTube and the company website.
https://www.youtube.com/@jenniferschaus/videos
Combined Illegal, Unregulated and Unreported (IUU) Vessel List.Christina Parmionova
The best available, up-to-date information on all fishing and related vessels that appear on the illegal, unregulated, and unreported (IUU) fishing vessel lists published by Regional Fisheries Management Organisations (RFMOs) and related organisations. The aim of the site is to improve the effectiveness of the original IUU lists as a tool for a wide variety of stakeholders to better understand and combat illegal fishing and broader fisheries crime.
To date, the following regional organisations maintain or share lists of vessels that have been found to carry out or support IUU fishing within their own or adjacent convention areas and/or species of competence:
Commission for the Conservation of Antarctic Marine Living Resources (CCAMLR)
Commission for the Conservation of Southern Bluefin Tuna (CCSBT)
General Fisheries Commission for the Mediterranean (GFCM)
Inter-American Tropical Tuna Commission (IATTC)
International Commission for the Conservation of Atlantic Tunas (ICCAT)
Indian Ocean Tuna Commission (IOTC)
Northwest Atlantic Fisheries Organisation (NAFO)
North East Atlantic Fisheries Commission (NEAFC)
North Pacific Fisheries Commission (NPFC)
South East Atlantic Fisheries Organisation (SEAFO)
South Pacific Regional Fisheries Management Organisation (SPRFMO)
Southern Indian Ocean Fisheries Agreement (SIOFA)
Western and Central Pacific Fisheries Commission (WCPFC)
The Combined IUU Fishing Vessel List merges all these sources into one list that provides a single reference point to identify whether a vessel is currently IUU listed. Vessels that have been IUU listed in the past and subsequently delisted (for example because of a change in ownership, or because the vessel is no longer in service) are also retained on the site, so that the site contains a full historic record of IUU listed fishing vessels.
Unlike the IUU lists published on individual RFMO websites, which may update vessel details infrequently or not at all, the Combined IUU Fishing Vessel List is kept up to date with the best available information regarding changes to vessel identity, flag state, ownership, location, and operations.
Lewy body dementia was first discovered in the early 1900s and involves protein deposits in the brain that affect brain function and cause Parkinson's-like symptoms. It can be difficult to diagnose due to similarities with Parkinson's disease, but indicators include progressive cognitive decline, fluctuating cognition and attention, visual hallucinations, and REM sleep behavior disorder. Treatments include medications to slow cognitive decline and manage Parkinsonism symptoms, as well as non-pharmacological therapies and counseling. An accurate diagnosis allows for better symptom management and quality of life.
Dementias are acquired cognitive impairments that affect memory, language, visuospatial ability, and other mental functions, impairing daily living. The most common type is Alzheimer's disease, which results from neuronal disruption and loss. A thorough evaluation involves assessing onset and progression of symptoms, neuropsychiatric features, physical exam including brief cognitive tests, and ruling out other treatable causes. The leading cause is Alzheimer's disease, whose risk increases dramatically with age and involves memory loss and other cognitive deficits that gradually worsen over years.
RUNNING HEAD Medical Disorders2Periodic Limb Moveme.docxtodd581
RUNNING HEAD: Medical Disorders 2
Periodic Limb Movement Disorder & Restless Leg Syndrome
Chelsea Reese
The University of Alabama at Birmingham
PSY 488: Kristin T. Avis, Ph.D., CBSM
December 14, 2018
Abstract
The restless legs syndrome (RLS) and periodic limb movement disorder (PLMD) can be separated but overlapping sicknesses. Both feature night-living happening by chance, without any planning occasional limb movements that can cause sleep disruption, but each has separate medicine-based features that are clearly connected with or related to the management of the patient. The cause of RLS is made by meeting established medicine-based judging needed things, not from discovery of occasional limb movements of sleep (PLMS) on a sleep study. PLMD does require the presence of PLMS on polysomnography as well as a connected sleep complaint. Both PLMS and RLS can happen with other sleep problems as well as in healthy people. Treatment of RLS is based on the pattern and extremeness of the problem, with rgic drugs generally liked for/preferred for first treatment. Anticonvulsants, pain-relieving drugs, and drugs that cause sleep also have a role. A treatment set of computer instructions is given to help with the management of RLS. Treatment of PLMD depends on many of the same medicines but is generally more plain/honest/easy and places a greater reliance on levodopa compounds and drug that calms or causes sleep.
Periodic Limb Movement Disorder (PLMD)
This disorder is characterized by repeated and uncontrollable movements of arms or legs occurring during sleep. This condition may affect the legs and arms and is sometimes confused with restless leg syndrome. This condition causes brief muscle twitches and leg kicks. The involuntary movements of limbs causes sleep disturbances or insomnia and a child suffering from this condition usually experiences other mental, physical, behavioral or social problems seen during the day.
As a result of disturbed sleep at night, the child may experience daytime sleepiness. However, the exact cause of this problem is not known but is associated with a family history of this condition. Low iron levels, nerve problems, poor blood circulation and kidney disorders are also common causes of this problem. This condition is also associated with other sleep problems such as narcolepsy and restless leg syndrome
To diagnose this problem, a parent may notice the signs at night when the child is sleeping, an overnight sleep study is often required to confirm the diagnosis along with other medical and physical examination such ad blood tests to determine the iron levels.
Treatment
Children and adolescents with PLMD are advised to have good sleep hygiene by having enough sleep and having regular sleep patterns, the children should also avoid caffeine as it worsens the symptoms of PLMD. In case the iron level are.
RUNNING HEAD Medical Disorders2Periodic Limb Moveme.docxglendar3
RUNNING HEAD: Medical Disorders 2
Periodic Limb Movement Disorder & Restless Leg Syndrome
Chelsea Reese
The University of Alabama at Birmingham
PSY 488: Kristin T. Avis, Ph.D., CBSM
December 14, 2018
Abstract
The restless legs syndrome (RLS) and periodic limb movement disorder (PLMD) can be separated but overlapping sicknesses. Both feature night-living happening by chance, without any planning occasional limb movements that can cause sleep disruption, but each has separate medicine-based features that are clearly connected with or related to the management of the patient. The cause of RLS is made by meeting established medicine-based judging needed things, not from discovery of occasional limb movements of sleep (PLMS) on a sleep study. PLMD does require the presence of PLMS on polysomnography as well as a connected sleep complaint. Both PLMS and RLS can happen with other sleep problems as well as in healthy people. Treatment of RLS is based on the pattern and extremeness of the problem, with rgic drugs generally liked for/preferred for first treatment. Anticonvulsants, pain-relieving drugs, and drugs that cause sleep also have a role. A treatment set of computer instructions is given to help with the management of RLS. Treatment of PLMD depends on many of the same medicines but is generally more plain/honest/easy and places a greater reliance on levodopa compounds and drug that calms or causes sleep.
Periodic Limb Movement Disorder (PLMD)
This disorder is characterized by repeated and uncontrollable movements of arms or legs occurring during sleep. This condition may affect the legs and arms and is sometimes confused with restless leg syndrome. This condition causes brief muscle twitches and leg kicks. The involuntary movements of limbs causes sleep disturbances or insomnia and a child suffering from this condition usually experiences other mental, physical, behavioral or social problems seen during the day.
As a result of disturbed sleep at night, the child may experience daytime sleepiness. However, the exact cause of this problem is not known but is associated with a family history of this condition. Low iron levels, nerve problems, poor blood circulation and kidney disorders are also common causes of this problem. This condition is also associated with other sleep problems such as narcolepsy and restless leg syndrome
To diagnose this problem, a parent may notice the signs at night when the child is sleeping, an overnight sleep study is often required to confirm the diagnosis along with other medical and physical examination such ad blood tests to determine the iron levels.
Treatment
Children and adolescents with PLMD are advised to have good sleep hygiene by having enough sleep and having regular sleep patterns, the children should also avoid caffeine as it worsens the symptoms of PLMD. In case the iron level are.
Neurocognitive disorders (NCDs) include conditions involving significant cognitive decline from previous levels of functioning. Major subtypes include those due to Alzheimer's disease, vascular factors, Lewy bodies, Parkinson's disease, frontotemporal deficits, traumatic brain injury, HIV, Huntington's disease, prion disease, or multiple etiologies. Delirium is characterized by acute changes in attention and cognition. Diagnosis of major or mild NCD due to conditions like Alzheimer's disease requires evidence of cognitive impairment in multiple domains interfering with daily life. Vascular NCD results from cerebrovascular disease and impairment occurs in step-like progression following small strokes in the brain.
The document discusses psychiatric manifestations that commonly occur in dementia such as Alzheimer's disease and dementia with Lewy bodies. It describes symptoms such as apathy, anxiety, agitation, and depression. Psychotic symptoms like hallucinations and delusions are also addressed. The prevalence of various neuropsychiatric symptoms is provided for mild cognitive impairment and different stages of Alzheimer's disease and dementia with Lewy bodies. Factors that influence the risk of developing certain psychiatric symptoms are also outlined.
This document discusses major and mild neurocognitive disorders. It defines neurocognitive disorders as involving cognitive decline and impairment, with mild disorders having slight decline in one function and major disorders having severe decline in one or more functions. It lists several types of neurocognitive disorders including Alzheimer's disease, vascular disorders, frontotemporal disorders, and disorders due to traumatic brain injury, Lewy bodies, Parkinson's disease, prion diseases, and substance abuse. Symptoms vary but include memory loss, confusion, impaired language and motor skills. Treatment involves testing, medication, and psychosocial support.
Presentation made by Drs. Charles Driscoll and Ms. Angela Taylor at the live webinar hosted by AlzPossible on the 29th of May, 2014. See recording at http://www.alzpossible.org/wordpress-3.1.4/wordpress/webinars-2/dementia-with-lewy-bodies/
The document summarizes key aspects of neurocognitive disorders as outlined in Chapter 7. It describes three main groups - delirium, major or minor neurocognitive disorders (dementia), and amnestic disorders. Delirium is a temporary state of confusion that can have various causes and usually resolves quickly if the underlying cause is treated. Dementia involves a gradual loss of cognitive abilities that impairs daily life; it has various causes like Alzheimer's disease or vascular issues. Assessment and management aim to address any underlying causes or provide support, as the condition is often not reversible.
The document provides information about East Central Regional Hospital and mental retardation/developmental disabilities. It discusses the hospital's mission, vision, and values in providing care. It then covers various topics related to mental retardation including definitions, classifications, causes, characteristics, diagnosis criteria. It notes the hospital serves those with mental illnesses, substance abuse, and mental retardation through a variety of treatment modalities.
This document provides information about dementia, including:
1. Dementia is characterized by progressive deterioration of intellect, behavior, and personality due to diffuse brain disease, especially affecting the cortex and hippocampus. Memory impairment is required for diagnosis.
2. Symptoms include memory loss, abnormal behavior, intellectual decline, mood changes, and difficulty with daily tasks. Insight is initially retained but lost over time.
3. Causes of dementia include Alzheimer's disease (60% of cases), cerebrovascular disease, neurodegenerative diseases, infections, head injuries, and tumors. Dementia must be distinguished from delirium and depression.
This document discusses different types and classifications of disabilities. It defines disability and outlines three dimensions recognized by the ICF: body structure/function, activities, and participation. It then describes common types of disabilities including physical, intellectual, sensory, and mental illnesses. Specific conditions are explained for each type. The document also discusses differences between impairments, disabilities, and handicaps.
P.S.Jagadeesh Kumar, "Bi-directional Recurrent Neural Networks in Classifying Dementia, Alzheimer’s Disease and Autism Spectrum Disorder", The Art of Fixing Alzheimer’s Disease, April, 2019, Dorrance Publishing Co., Pittsburgh, Pennsylvania, United States.
This document provides information on geriatric psychiatry and aging-related mental health issues. It discusses several key topics:
1. Age-related changes in physiological functioning can increase vulnerability over time. Late adulthood begins around age 65 and is characterized by gradual decline in functioning of body systems.
2. Life expectancy has been increasing in India and globally, leading to growth in the elderly population. Common concerns for elderly include retirement, economic insecurity, declining health, and loss of independence.
3. Major mental health disorders in elderly include depression, delirium, and dementia. Late-life depression can present differently than depression in younger populations. Delirium is an acute change in mental status that commonly affects hospital
Today Schizophrenia awareness week starts. (From 22 May 2022 to 28th May 2022). Theme for this year is "Connecting with Hope". I have tried my best to cover everything about schizophrenia a type of severe mental illness.
This document discusses delirium and dementia. It defines delirium as a disturbance of consciousness and cognition that develops rapidly. Common causes include medical conditions, substances, and trauma. Dementia involves a progressive decline in cognitive functions due to brain damage or disease. Alzheimer's disease is the most common cause of dementia. The document stages the progression of Alzheimer's disease from no symptoms to severe cognitive decline. It also discusses various types of dementia and their neurological underpinnings.
Dementia is an acquired global impairment of intellect, memory and personality but without impairment of consciousness“
Or
According to WHO
Dementia is a syndrome in which there is deterioration in cognitive function beyond what might be expected from the usual consequences of biological ageing.
Dementia is an umbrella term that can affect even young individuals. This presentation investigates causes, assessment, diagnosis, and treatment options.
Jennifer Schaus and Associates hosts a complimentary webinar series on The FAR in 2024. Join the webinars on Wednesdays and Fridays at noon, eastern.
Recordings are on YouTube and the company website.
https://www.youtube.com/@jenniferschaus/videos
Combined Illegal, Unregulated and Unreported (IUU) Vessel List.Christina Parmionova
The best available, up-to-date information on all fishing and related vessels that appear on the illegal, unregulated, and unreported (IUU) fishing vessel lists published by Regional Fisheries Management Organisations (RFMOs) and related organisations. The aim of the site is to improve the effectiveness of the original IUU lists as a tool for a wide variety of stakeholders to better understand and combat illegal fishing and broader fisheries crime.
To date, the following regional organisations maintain or share lists of vessels that have been found to carry out or support IUU fishing within their own or adjacent convention areas and/or species of competence:
Commission for the Conservation of Antarctic Marine Living Resources (CCAMLR)
Commission for the Conservation of Southern Bluefin Tuna (CCSBT)
General Fisheries Commission for the Mediterranean (GFCM)
Inter-American Tropical Tuna Commission (IATTC)
International Commission for the Conservation of Atlantic Tunas (ICCAT)
Indian Ocean Tuna Commission (IOTC)
Northwest Atlantic Fisheries Organisation (NAFO)
North East Atlantic Fisheries Commission (NEAFC)
North Pacific Fisheries Commission (NPFC)
South East Atlantic Fisheries Organisation (SEAFO)
South Pacific Regional Fisheries Management Organisation (SPRFMO)
Southern Indian Ocean Fisheries Agreement (SIOFA)
Western and Central Pacific Fisheries Commission (WCPFC)
The Combined IUU Fishing Vessel List merges all these sources into one list that provides a single reference point to identify whether a vessel is currently IUU listed. Vessels that have been IUU listed in the past and subsequently delisted (for example because of a change in ownership, or because the vessel is no longer in service) are also retained on the site, so that the site contains a full historic record of IUU listed fishing vessels.
Unlike the IUU lists published on individual RFMO websites, which may update vessel details infrequently or not at all, the Combined IUU Fishing Vessel List is kept up to date with the best available information regarding changes to vessel identity, flag state, ownership, location, and operations.
This report explores the significance of border towns and spaces for strengthening responses to young people on the move. In particular it explores the linkages of young people to local service centres with the aim of further developing service, protection, and support strategies for migrant children in border areas across the region. The report is based on a small-scale fieldwork study in the border towns of Chipata and Katete in Zambia conducted in July 2023. Border towns and spaces provide a rich source of information about issues related to the informal or irregular movement of young people across borders, including smuggling and trafficking. They can help build a picture of the nature and scope of the type of movement young migrants undertake and also the forms of protection available to them. Border towns and spaces also provide a lens through which we can better understand the vulnerabilities of young people on the move and, critically, the strategies they use to navigate challenges and access support.
The findings in this report highlight some of the key factors shaping the experiences and vulnerabilities of young people on the move – particularly their proximity to border spaces and how this affects the risks that they face. The report describes strategies that young people on the move employ to remain below the radar of visibility to state and non-state actors due to fear of arrest, detention, and deportation while also trying to keep themselves safe and access support in border towns. These strategies of (in)visibility provide a way to protect themselves yet at the same time also heighten some of the risks young people face as their vulnerabilities are not always recognised by those who could offer support.
In this report we show that the realities and challenges of life and migration in this region and in Zambia need to be better understood for support to be strengthened and tuned to meet the specific needs of young people on the move. This includes understanding the role of state and non-state stakeholders, the impact of laws and policies and, critically, the experiences of the young people themselves. We provide recommendations for immediate action, recommendations for programming to support young people on the move in the two towns that would reduce risk for young people in this area, and recommendations for longer term policy advocacy.
Monitoring Health for the SDGs - Global Health Statistics 2024 - WHOChristina Parmionova
The 2024 World Health Statistics edition reviews more than 50 health-related indicators from the Sustainable Development Goals and WHO’s Thirteenth General Programme of Work. It also highlights the findings from the Global health estimates 2021, notably the impact of the COVID-19 pandemic on life expectancy and healthy life expectancy.
Food safety, prepare for the unexpected - So what can be done in order to be ready to address food safety, food Consumers, food producers and manufacturers, food transporters, food businesses, food retailers can ...
Working with data is a challenge for many organizations. Nonprofits in particular may need to collect and analyze sensitive, incomplete, and/or biased historical data about people. In this talk, Dr. Cori Faklaris of UNC Charlotte provides an overview of current AI capabilities and weaknesses to consider when integrating current AI technologies into the data workflow. The talk is organized around three takeaways: (1) For better or sometimes worse, AI provides you with “infinite interns.” (2) Give people permission & guardrails to learn what works with these “interns” and what doesn’t. (3) Create a roadmap for adding in more AI to assist nonprofit work, along with strategies for bias mitigation.
Jennifer Schaus and Associates hosts a complimentary webinar series on The FAR in 2024. Join the webinars on Wednesdays and Fridays at noon, eastern.
Recordings are on YouTube and the company website.
https://www.youtube.com/@jenniferschaus/videos
Donate to charity during this holiday seasonSERUDS INDIA
For people who have money and are philanthropic, there are infinite opportunities to gift a needy person or child a Merry Christmas. Even if you are living on a shoestring budget, you will be surprised at how much you can do.
Donate Us
https://serudsindia.org/how-to-donate-to-charity-during-this-holiday-season/
#charityforchildren, #donateforchildren, #donateclothesforchildren, #donatebooksforchildren, #donatetoysforchildren, #sponsorforchildren, #sponsorclothesforchildren, #sponsorbooksforchildren, #sponsortoysforchildren, #seruds, #kurnool
The Antyodaya Saral Haryana Portal is a pioneering initiative by the Government of Haryana aimed at providing citizens with seamless access to a wide range of government services
1. Lewy Body Dementia: Understanding the
Complexities of This Common but
Underdiagnosed Disorder
Lewy Body Dementia (LBD) is a complex neurodegenerative disorder that affects
millions of people worldwide. Despite its prevalence, LBD often remains
underdiagnosed, presenting a significant challenge in understanding and managing
the condition.
This blog post aims to shed light on the complexities of LBD and bring awareness to
the need for timely and accurate diagnosis. By exploring the unique characteristics of
LBD and the obstacles faced in identifying the disorder, we can enhance our
understanding of this commonly overlooked condition and improve the lives of those
affected by it.
Understanding The Biology of LBD
Lewy Body Dementia (LBD) is characterized by the presence of abnormal protein
deposits called Lewy bodies in the brain. These Lewy bodies are composed mainly
of a protein called alpha-synuclein and are found in specific areas of the brain,
including the cerebral cortex and brainstem.
2. The accumulation of Lewy bodies interferes with the normal functioning of brain
cells, leading to a wide range of cognitive, behavioral, and motor symptoms.
Cognitive impairment in LBD often includes problems with attention, executive
function, and visual-spatial abilities. Additionally, individuals with LBD may
experience fluctuating levels of alertness and attention, which can make diagnosis
and management challenging.
In addition to cognitive symptoms, LBD also presents with motor symptoms similar to
Parkinson's disease. These symptoms may include muscle stiffness, tremors,
shuffling gait, and balance difficulties. The co-occurrence of both cognitive and motor
symptoms distinguishes LBD from other types of Dementia.
Comparing LBD To Other Types of Dementia
LBD shares some similarities with other types of Dementia, particularly Alzheimer's
disease and Parkinson's disease Dementia (PDD). However, there are distinct
features that set LBD apart.
Compared to Alzheimer's disease, LBD often has a more rapid progression of
cognitive decline and a greater impact on attention and visual-spatial abilities.
Additionally, individuals with LBD may experience visual hallucinations early in the
disease, which is less common in Alzheimer's.
When compared to PDD, LBD and Parkinson's disease may have overlapping
symptoms such as motor impairment, but LBD typically presents with cognitive
symptoms earlier in the disease course, often before or concurrently with motor
symptoms. Furthermore, individuals with LBD are more prone to experience
fluctuations in cognition and alertness, as well as visual hallucinations, compared to
those with PDD.
Recognizing The Symptoms of LBD
Understanding the typical symptoms of LBD is crucial for early recognition and
appropriate management. However, it's important to note that the presentation of
symptoms can vary significantly from person to person, making LBD a challenging
condition to diagnose and treat.
Cognitive Symptoms: LBD often leads to cognitive impairments similar to those
seen in Alzheimer's disease. These may include difficulties with memory, attention,
problem-solving, and judgment. However, in LBD, fluctuations in cognition are
particularly prominent. People with LBD may experience sudden changes in
alertness, attention, and confusion, often described as "good days" and "bad days."
These fluctuations can make it challenging to perform daily tasks and contribute to
the variability in symptom presentation.
3. Visual Hallucinations: Visual hallucinations are a hallmark symptom of LBD. These
hallucinations are typically vivid and detailed, involving seeing people, animals, or
objects that are not present. They may be fleeting or persistent and can cause
significant distress for individuals with LBD and their caregivers.
Motor Symptoms: LBD is also associated with motor symptoms similar to
Parkinson's disease. These can include muscle stiffness, tremors, bradykinesia
(slowness of movement), shuffling gait, and postural instability. Parkinsonism
symptoms may be present earlier or develop later in the disease course.
Autonomic Dysfunction: LBD affects the autonomic nervous system, leading to
dysfunctions such as fluctuations in blood pressure, heart rate, and body
temperature. These dysfunctions can result in dizziness, falls, and problems with
bladder and bowel control.
Sleep Disorders: Sleep disturbances are common in LBD, including REM sleep
behavior disorder (RBD), where individuals act out their dreams. Other sleep-related
issues may include excessive daytime sleepiness, insomnia, and fragmented sleep
patterns.
Psychiatric And Behavioral Symptoms: LBD can cause significant changes in
mood, behavior, and personality. Depression and anxiety are frequently observed,
as well as apathy, agitation, irritability, and impulsivity. Delusions and paranoid
thoughts may also occur.
Sensitivity To Medications: People with LBD are highly sensitive to certain
medications, including antipsychotics and some anesthesia drugs. These
medications can worsen symptoms or cause severe adverse reactions, such as
increased confusion, delirium, or even neuroleptic malignant syndrome.
Cognitive And Behavioral Manifestations of LBD
Lewy Body Dementia (LBD) presents a diverse array of cognitive and behavioral
manifestations that profoundly impact individuals' lives.
Cognitive symptoms in LBD can be characterized by
Fluctuating cognition, where attention, alertness, and clarity of thinking
vary throughout the day.
Executive dysfunction, affecting planning, decision-making, and
multitasking, is also common.
Although memory impairment is typically milder compared to
Alzheimer's disease, short-term memory difficulties may arise.
4. Visuospatial and perceptual challenges, such as depth perception
issues and visual misinterpretations, can contribute to spatial
disorientation.
LBD is also associated with distinct behavioral manifestations.
Visual hallucinations, often vivid and complex, are a hallmark of LBD
and may cause significant distress.
Psychiatric symptoms, including depression, anxiety, apathy, and
irritability, frequently occur.
Mood swings, impulsivity, and disinhibition can disrupt emotional well-
being and social interactions.
Sleep disturbances, such as REM sleep behavior disorder and
fragmented sleep patterns, further compound cognitive and behavioral
challenges.
Delusions and paranoia, with individuals harboring false beliefs or
exhibiting suspiciousness, may also arise.
It's important to note that the presence and severity of cognitive and behavioral
symptoms can vary among individuals with LBD. A comprehensive assessment by
healthcare professionals with expertise in LBD is crucial for accurate diagnosis and
tailored management strategies. By addressing these cognitive and behavioral
manifestations, individuals with LBD can receive the appropriate support and care to
enhance their well-being and maintain their quality of life.
The Course And Progression of LBD
The course and progression of LBD can vary from person to person, but there are
general patterns that can be observed.
Early Stages
In the early stages of LBD, individuals may experience mild cognitive and behavioral
changes. These can include fluctuations in attention and alertness, problems with
memory and executive function, visual hallucinations, and mood disturbances. Motor
symptoms, such as muscle stiffness and tremors, may also be present, resembling
Parkinson's disease.
Progression
As LBD progresses, cognitive decline becomes more pronounced, with increasing
difficulties in memory, problem-solving, and language. Fluctuations in cognition may
become more frequent and severe, leading to greater challenges in daily functioning.
Motor symptoms may also worsen, affecting mobility, balance, and coordination.
Later Stages
In the later stages of LBD, individuals often require significant assistance with
activities of daily living. Cognitive impairment becomes severe, with individuals
experiencing profound memory loss, disorientation, and difficulty recognizing loved
5. ones. Motor symptoms may include severe muscle rigidity, bradykinesia (slowness
of movement), and postural instability, making walking and movement extremely
challenging.
As LBD progresses, individuals may develop complications related to swallowing
difficulties, increased risk of falls, and susceptibility to infections. Caregiver support
and assistance become crucial in managing the complex needs of individuals with
advanced LBD.
It's important for individuals and their caregivers to work closely with healthcare
professionals experienced in LBD to establish a care plan that addresses the
evolving needs and challenges at each stage of the disease. By understanding the
course and progression of LBD, individuals and their caregivers can be better
prepared to navigate the journey and access appropriate support and resources.
Living With LBD: Personal Narratives
Living with Lewy Body Dementia (LBD) can be an arduous journey, not only for the
individuals affected but also for their caregivers and families. LBD is a complex
neurodegenerative disorder that presents a unique set of challenges, combining the
symptoms of both Parkinson's disease and Alzheimer's disease.
Equally important is understanding the impact of LBD on caregivers and families.
Providing care for someone with LBD demands immense patience, empathy, and
support. Caregivers often face physical, emotional, and financial strain as they
navigate the complexities of the disease. Witnessing a loved one's decline can be
emotionally taxing, and the need for support networks and resources becomes
paramount.
Current Treatment Strategies in LBD Research
When it comes to treatment, managing LBD requires a multidisciplinary approach.
Current strategies focus on symptom management, including medications to address
movement issues and cognitive symptoms. However, there is still no cure for LBD,
and available treatments aim to improve quality of life and minimize the impact of
symptoms. Careful monitoring of medication regimens, addressing sleep
disturbances, and managing psychiatric symptoms are crucial components of LBD
treatment.
Despite the challenges, there is hope on the horizon. Recent research
advancements in LBD are paving the way for a better understanding of the disease
and potential breakthroughs in treatment. Scientists and medical professionals are
6. working tirelessly to unravel the underlying mechanisms of LBD, develop more
targeted therapies, and explore potential biomarkers for early detection. With each
research study, we move closer to improved diagnostic tools and innovative
interventions that may slow down or halt the progression of the disease.
Conclusion
Living with LBD is an intricate journey filled with unique challenges. Personal
narratives from individuals living with LBD remind us of the strength and resilience
within the community. Caregivers and families play a vital role in supporting their
loved ones, but they also need support themselves. As we strive for increased
recognition of LBD, it is essential to advocate for further research, funding, and
resources. By continuing to shed light on this complex disease, we can bring hope to
individuals with LBD and their families, and work towards a brighter future. For more
details, you can visit the Dementia Society.